Inventor
RELO ANA-LUCIA
DE20 patents
⚠️ This page may combine multiple inventors who share the name “RELO ANA-LUCIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE DEUTSCHLAND
8 patentsUS10118926B2Nov 6, 2018
Tricyclic quinoline and quinoxaline derivatives
ABBVIE DEUTSCHLAND10 citations81
US9573950B2Feb 21, 2017
Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators
ABBVIE DEUTSCHLAND2 citations57
US9994568B2Jun 12, 2018
Tricyclic quinoline and quinoxaline derivatives
ABBVIE DEUTSCHLAND0 citations50
US9701679B2Jul 11, 2017
Modulators of 5-HT receptors and methods of use thereof
ABBVIE DEUTSCHLAND0 citations50
US9169253B2Oct 27, 2015
Tricyclic quinoline and quinoxaline derivatives
ABBVIE DEUTSCHLAND1 citations50
US9879033B2Jan 30, 2018
Modulators of 5-HT receptors and methods of use thereof
ABBVIE DEUTSCHLAND0 citations49
US10160744B2Dec 25, 2018
Quinoline compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor
ABBVIE DEUTSCHLAND0 citations41
US9540376B2Jan 10, 2017
Hexahydrodiazepinoquinolines carrying a substituted alkyl radical
ABBVIE DEUTSCHLAND0 citations35
HAUPT ANDREAS
4 patentsUS8076326B2Dec 13, 2011
N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
HAUPT ANDREAS23 citations90
US8772313B2Jul 8, 2014
Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor
HAUPT ANDREAS2 citations62
US8710059B2Apr 29, 2014
N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor
HAUPT ANDREAS3 citations62
US8183237B2May 22, 2012
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
HAUPT ANDREAS4 citations60
ABBOTT GMBH & CO KG
2 patentsUS8343959B2Jan 1, 2013
N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
ABBOTT GMBH & CO KG5 citations72
US8362010B2Jan 29, 2013
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
ABBOTT GMBH & CO KG2 citations61